Global Med Technologies(R) Signs Binding Letter of Intent to Acquire Hemo-Net(R) Medical Industry Application Service Provider
October 06 2009 - 9:00AM
PR Newswire (US)
"Tuck-in" Purchase Will Add Fully Integrated ASP Solution to Suite
of Products DENVER, Oct. 6 /PRNewswire-FirstCall/ -- Global Med
Technologies®, Inc. ("Global Med" or the "Company") (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international healthcare information
technology company, today announced that it has signed a binding
letter of intent with Denver-based Bonfils Blood Center to acquire
Hemo-Net®. A subsidiary of the blood center, Hemo-Net is a
pioneering application service provider (ASP) specializing in the
medical technology field. Hemo-Net is based in Denver, Colorado.
Hemo-Net currently hosts business solutions for Global Med's
customers in the United States and Africa. Hemo-Net's revenues in
the next calendar year will be approximately $900,000, with an
expected positive EBIDTA. The acquisition is expected to close by
November 1, 2009. Terms of the agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Created
in 2003, Hemo-Net provides secure, highly-available and
cost-effective software hosting applications with a strong
understanding of its impact on the success of healthcare
organizations. Hemo-Net is responsible for the maintenance and
availability of mission critical applications and the security of
the machines that serve those applications. Data is secured in
multiple locations so that it maintains its integrity, especially
in the event of natural or man-made disasters. Hosting is also an
excellent solution for providing advanced healthcare systems to
areas in the world where scarce resources prevent most modern
systems from being implemented. Hemo-Net's ASP service provides a
secure and cost-effective method for blood centers and hospitals to
purchase systems or upgrade their current software to
state-of-the-art systems without incurring the costs associated
with purchasing and maintaining their own equipment. Michael I.
Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc.,
commented, "The acquisition of Hemo-Net is expected to complement
Global Med's strong line of international blood management and
laboratory information software and service solutions by offering
alternative hosting methods. We have seen first hand the invaluable
nature of offering our customers a hosted solution. In fact,
Hemo-Net was indispensable in assisting our customer, The Blood
Center of New Orleans, to quickly resume operations after Hurricane
Katrina in 2005. From its Denver headquarters, Hemo-Net was able to
remotely restore The Blood Center's critical IT functions." Dr.
Ruxin continued, "We understand the industry's need for advanced
healthcare solutions and the monetary constraints placed on
healthcare organizations in today's economy. Global Med's
acquisition of Hemo-Net is a vital piece of the Company's overall
corporate strategy to provide comprehensive and flexible business
solutions to our customers." Thomas C. Puckett, President and Chief
Executive Officer of Bonfils Blood Center, stated, "We are very
pleased that our long-time vendor and trusted partner, Global Med
Technologies, will be taking ownership of Hemo-Net. We have the
utmost confidence that Global Med will continue to provide
outstanding service for Bonfils and our existing blood center
clients. We also believe that Global Med is uniquely positioned to
grow the business and bring ASP services to healthcare centers
around the world." About Bonfils Blood Center For more than 65
years, the Colorado-based Bonfils Blood Center has successfully
managed the community blood supply and played an integral role in
Colorado's healthcare system. Bonfils Blood Center supplies blood
to nearly 200 healthcare facilities across the state and beyond and
needs to collect more than 3,300 blood donations each week to meet
the needs of the community and to be prepared for any unexpected
events. For information about Bonfils Blood Center please call
800.365.0006 or visit http://www.bonfils.org/. About Global Med
Technologies®, Inc. Global Med Technologies, Inc. is an
international healthcare information technology company which
develops regulated and non-regulated products and services for the
healthcare industry. As a leading provider of blood and laboratory
systems and services, Global Med's products are deployed in 20
countries and serve over 2,100 transfusion centers, blood banks and
laboratory sites. Global Med's domestic companies are Wyndgate
Technologies®, a leader in software products and services for donor
centers and hospital transfusion services; eDonor®, which offers
web-based donor relationship management systems; and PeopleMed(TM),
Inc., which implements cost-effective software validation,
consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer
of donor center and transfusion management systems as well as
cellular therapy software, laboratory information systems and
quality assurance medical software systems internationally. For
more information about Global Med's products and services, please
call 800-996-3428 or visit http://www.globalmedtech.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: company, Michael I. Ruxin, M.D. of Global Med
Technologies, Inc., +1-303-238-2000, or investors, Jeffrey Benison,
+1-212-334-8709, ; or Blood Center, Bonfils Blood Center, Julie
Scott, PR Specialist, +1-303-361-2873, Web Site:
http://www.globalmedtech.com/ http://www.bonfils.org/
Copyright